Equity

AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss

Moderna AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss decreased by 4.2% to $271.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 80.0%, from $1.36B to $271.00M. Over 4 years (FY 2021 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss shows an upward trend with a 310.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
Metric ID: afs_debt_securities_unrealized_loss_12m_plus_acc

Historical Data

18 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.00M$1.00M$517.00M$3.65B$5.52B$7.70B$8.15B$7.40B$6.64B$5.10B$4.80B$3.58B$2.64B$1.36B$567.00M$499.00M$283.00M$271.00M
QoQ Change—+0.0%>999%+605.2%+51.5%+39.4%+5.9%-9.2%-10.2%-23.3%-5.8%-25.5%-26.1%-48.7%-58.2%-12.0%-43.3%-4.2%
YoY Change————>999%>999%>999%+103.0%+20.3%-33.8%-41.1%-51.7%-60.2%-73.4%-88.2%-86.1%-89.3%-80.0%
Range$1.00M – $8.15B
CAGR+273.6%
Avg YoY Growth>999%
Median YoY Growth-46.4%
Current Streak11 quarters decline

Frequently Asked Questions

What is Moderna's afs and trading securities - unrealized loss position (>=12 months) accumulated loss?
Moderna (MRNA) reported afs and trading securities - unrealized loss position (>=12 months) accumulated loss of $271.00M in Q1 2026.
How has Moderna's afs and trading securities - unrealized loss position (>=12 months) accumulated loss changed year-over-year?
Moderna's afs and trading securities - unrealized loss position (>=12 months) accumulated loss decreased by 80.0% year-over-year, from $1.36B to $271.00M.
What is the long-term trend for Moderna's afs and trading securities - unrealized loss position (>=12 months) accumulated loss?
Over 4 years (2021 to 2025), Moderna's afs and trading securities - unrealized loss position (>=12 months) accumulated loss has grown at a 310.2% compound annual growth rate (CAGR), from $1.00M to $283.00M.